IGF-I in major depression and antidepressant treatment response.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  European Neuropsychopharmacology

• Publication date

  2015-06-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1016/j.euroneuro.2014.12.013PMID 25836355
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• IGF-I levels and depressive disorders: results from the Study of Health in Pomerania (SHIP).

  2014cited by this paper
• A Robust Method for Genome‐Wide Association Meta‐Analysis With the Application to Circulating Insulin‐Like Growth Factor I Concentrations

  2014influential reference
• The Stress Response to Surgery and Postoperative Delirium

  2013cited by this paper
• Common genetic variation and antidepressant efficacy in major depressive disorder: a meta-analysis of three genome-wide pharmacogenetic studies.

  2013cited by this paper
• A mega-analysis of genome-wide association studies for major depressive disorder

  2013cited by this paper
• Insulin-like growth factors in the brain and their potential clinical implications

  2012cited by this paper
• Modulation of glucocorticoid metabolism by the GH-IGF-I axis.

  2011cited by this paper
• The Corticotropin-Releasing Hormone Network and the Hypothalamic-Pituitary-Adrenal Axis: Molecular and Cellular Mechanisms Involved

  2011cited by this paper
• Treatment with antidepressants increases insulin-like growth factor-I in cerebrospinal fluid.

  2011cited by this paper
• The neuronal transporter gene SLC6A15 confers risk to major depression.

  2011cited by this paper
• Consensus statement on the standardization and evaluation of growth hormone and insulin-like growth factor assays.

  2011cited by this paper
• Prevalence and treatment outcome in anxious versus nonanxious depression: results from the German Algorithm Project.

  2010cited by this paper
• The current status of IGF-I assays--a 2009 update.

  2010cited by this paper
• Polymorphisms in GRIK4, HTR2A, and FKBP5 Show Interactive Effects in Predicting Remission to Antidepressant Treatment

  2010cited by this paper
• Toward a comprehensive neurobiology of IGF‐I

  2010cited by this paper
• Glucocorticoids

  2009cited by this paper
• Insulin-like Growth Factor-I (IGF-I) Serum Concentrations in Depressed Patients: Relationship to Saliva Cortisol and Changes during Antidepressant Treatment

  2009cited by this paper
• Growth Hormone Inhibits the 11β-Hydroxysteroid Dehydrogenase Type 1 Gene Promoter Activity via Insulin-like Growth Factor I in HepG2 Cells

  2008cited by this paper
• Clinical characteristics and treatment outcome in a representative sample of depressed inpatients - findings from the Munich Antidepressant Response Signature (MARS) project.

  2008cited by this paper
• Insulin-like growth factor-1 in plasma and brain: regulation in health and disease.

  2008cited by this paper
• Combined dexamethasone/corticotropin releasing hormone test predicts treatment response in major depression - a potential biomarker?

  2007cited by this paper
• Changes in the Hypothalamic-Pituitary-Adrenal Axis and Leptin Levels during Antidepressant Treatment

  2007cited by this paper
• Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment

  2004cited by this paper
• Cortisol response in the combined dexamethasone/CRH test as predictor of relapse in patients with remitted depression. a prospective study.

  2001cited by this paper
• Randomized, double-blind comparison of venlafaxine and sertraline in outpatients with major depressive disorder. Venlafaxine 631 Study Group.

  2000cited by this paper
• The Corticosteroid Receptor Hypothesis of Depression

  2000cited by this paper
• Modulation of 11beta-hydroxysteroid dehydrogenase isozymes by growth hormone and insulin-like growth factor: in vivo and in vitro studies.

  1999cited by this paper
• Dexamethasone Impairs Growth Hormone (GH)-Stimulated Growth by Suppression of Local Insulin-Like Growth Factor (IGF)-I Production and Expression of GH- and IGF-I-Receptor in Cultured Rat Chondrocytes.

  1998cited by this paper
• The Role of the Insulin-Like Growth Factor System in the Developing Brain

  1998cited by this paper
• Insulin-like growth factor-I (IGF-I) plasma concentrations are increased in depressed patients.

  1997cited by this paper
• Antidepressants and hypothalamic-pituitary-adrenocortical regulation.

  1996cited by this paper
• Insulin-like growth factors cross the blood-brain barrier.

  1994cited by this paper
• Effects of glucocorticoids on circulating levels and hepatic expression of insulin-like growth factor (IGF)-binding proteins and IGF-I in the adrenalectomized streptozotocin-diabetic rat.

  1993cited by this paper
• Loss of glucocorticoid fast feedback in depression.

  1991cited by this paper
• Cortisol inhibits the synthesis of insulin-like growth factor-I in skeletal cells.

  1990cited by this paper
• Effects of glucocorticoids on the regulation of the hypothalamic-pituitary-somatotropic system in depression.

  1989cited by this paper
• Insulin‐like growth factor I in depressed patients and controls

  1988cited by this paper

• Efficacy and Safety of Toludesvenlafaxine Hydrochloride Sustained-Release Tablets in Depression With Anhedonia: A Single-Arm, Multicenter Clinical Study

  2025cites this paper
• The Insulin-like Growth Factor Family as a Potential Peripheral Biomarker in Psychiatric Disorders: A Systematic Review

  2025cites this paper
• Developing an individual depression risk score based on traditional risk factors and routine biochemical markers.

  2024cites this paper
• Effects of an acute maximal exercise bout on serum insulin-like growth factor-1 in adults with MDD.

  2024influential citation
• Association between IGF-1 levels and MDD: a case-control and meta-analysis

  2024cites this paper
• Under the umbrella of depression and Alzheimer's disease physiopathology: can cannabinoids be a dual-pleiotropic therapy?

  2023cites this paper
• Serum cortisol and insulin-like growth factor 1 levels in major depressive disorder and schizophrenia

  2023cites this paper
• Association between insulin resistance and serum insulin-like growth factor 1 levels in patients with non-remitting major depressive disorder.

  2023cites this paper
• Protein Plasma Levels of the IGF Signalling System Are Altered in Major Depressive Disorder

  2023influential citation
• Research Progress of Depression and Endocrine Hormones

  2023cites this paper
• Insulin-like growth factor 1 regulates excitatory synaptic transmission in pyramidal neurons from adult prefrontal cortex.

  2022cites this paper
• Xiaoyaosan ethyl acetate fraction alleviates depression-like behaviors in CUMS mice by promoting hippocampal neurogenesis via modulating the IGF-1Rβ/PI3K/Akt signaling pathway.

  2022cites this paper
• Integrated Module of Multidimensional Omics for Peripheral Biomarkers (iMORE) in patients with major depressive disorder: rationale and design of a prospective multicentre cohort study

  2022cites this paper
• Association of the Combined Effects between Insulin-Like Growth Factor-1 Gene Polymorphisms and Negative Life Events with Major Depressive Disorder among Chinese population in the Context of Oxidative Stress

  2022cites this paper
• DNA Methylation Markers and Prediction Model for Depression and Their Contribution for Breast Cancer Risk

  2022cites this paper
• The Role of Neurotrophic Factors in Pathophysiology of Major Depressive Disorder.

  2021cites this paper
• IGF-1 as selected growth factor multi-response to antidepressant-like substances activity in C57BL/6J mouse testis model.

  2021cites this paper
• Bioinformatics analysis of gene expression profile in women with major depressive disorder

  2021cites this paper
• PCOS and Depression: Common Links and Potential Targets

  2021cites this paper
• Differential effects of ergometer-cycling and Whole-Body-Vibration training on serological BDNF and IGF-1 in the treatment of adolescent depression - is there an impact of BDNF-p.Val66Met variants?

  2021cites this paper
• Telomeres: the role of shortening and senescence in major depressive disorder and its therapeutic implications

  2021cites this paper
• Effects of Antidepressant Treatment on Neurotrophic Factors (BDNF and IGF-1) in Patients with Major Depressive Disorder (MDD)

  2021cites this paper
• Clinical laboratory tests and five-year incidence of major depressive disorder: a prospective cohort study of 433,890 participants from the UK Biobank

  2021cites this paper
• A Retrospective Study of the Effects of Psychotropic Drugs on Neuroendocrine Hormones in Patients with Bipolar Disorder

  2021cites this paper
• Relationship between hepatocellular carcinoma and depression via online database analysis

  2021cites this paper
• Role of Polyinosinic:Polycytidylic Acid-Induced Maternal Immune Activation and Subsequent Immune Challenge in the Behaviour and Microglial Cell Trajectory in Adult Offspring: A Study of the Neurodevelopmental Model of Schizophrenia

  2021cites this paper
• NDT_A_306458 1543..1550

  2021cites this paper
• Value of peripheral neurotrophin levels for the diagnosis of depression and response to treatment: A systematic review and meta-analysis.

  2020cites this paper
• Major depressive disorder and accelerated aging from a peripheral IGF-1 overexpression perspective.

  2020cites this paper
• Serum insulin-like growth factor-1 as a potential marker for MDD diagnosis, its clinical characteristics, and treatment efficacy validation: data from an open-label vortioxetine study

  2020cites this paper
• Serum insulin-like growth factor-1 and relaxin-3 are linked with major depressive disorder.

  2020cites this paper
• Implications of Insulin-Like Growth Factor-1 in Skeletal Muscle and Various Diseases

  2020cites this paper
• The Diagnostic Value of the Combination of Serum Brain-Derived Neurotrophic Factor and Insulin-Like Growth Factor-1 for Major Depressive Disorder Diagnosis and Treatment Efficacy

  2020cites this paper
• Depression: Biological markers and treatment

  2020cites this paper
• Identification of Crucial Genes and Diagnostic Value Analysis in Major Depressive Disorder Using Bioinformatics Analysis.

  2020cites this paper
• Whole Body Vibration Training Improves Depression-like Behaviors in a Rat Chronic Restraint Stress Model.

  2020cites this paper
• Peripheral IGF-1 in bipolar disorder and major depressive disorder: a systematic review and meta-analysis.

  2020influential citation
• Hormonal Dynamics Effect of Serum Insulin-Like Growth Factor I and Cortisol/Dehydroepiandrosterone Sulfate Ratio on Symptom Severity of Major Depressive Disorder.

  2019cites this paper
• A diabetes és a depresszió együttes előfordulása, lehetséges kétirányú kapcsolata és szűrésük jelentősége

  2019cites this paper
• Psychotropic medication effects on cortisol: Implications for research and mechanisms of drug action.

  2019cites this paper
• Novel adenoviral IGF-I administration modulates the association between depressive symptoms and aging: Does gender matter?

  2019cites this paper
• INSULIN-LIKE GROWTH FACTOR-1 OVEREXPRESSION MEDIATES HIPPOCAMPAL REMODELING AND PLASTICITY FOLLOWING TBI

  2018cites this paper
• Antidepressant-like effects of insulin and IGF-1 are mediated by IGF-1 receptors in the brain.

  2018cites this paper
• Neurotrophic factors and neuroplasticity pathways in the pathophysiology and treatment of depression

  2018cites this paper
• IGF‐1 defends against chronic‐stress induced depression in rat models of chronic unpredictable mild stress through the PI3K/Akt/FoxO3a pathway

  2018cites this paper
• The genetic overlap between mood disorders and cardiometabolic diseases: a systematic review of genome wide and candidate gene studies

  2017cites this paper
• Differential exosomal microRNA profile in the serum of a patient with depression

  2017cites this paper
• MicroRNA-Mediated Regulation of ITGB3 and CHL1 Is Implicated in SSRI Action

  2017cites this paper
• Insulin-like growth factor-1: a possible marker for emotional and cognitive disturbances, and treatment effectiveness in major depressive disorder

  2017cites this paper
• SAT0037 Duration of Immune Response To Influenza Vaccination in Patients with Rheumatoid Arthritis Treated with Biological Agents

  2016cites this paper
• Microglial dysfunction connects depression and Alzheimer's disease.

  2016cites this paper
• Depression as a risk factor for Alzheimer's disease: Genes, steroids, cytokines and neurogenesis - What do we need to know?

  2016cites this paper
• IGF-I biomarker testing in an ethical context

  2016cites this paper
• Genetic Overlap Between Depression and Cardiometabolic Disorders

  2016cites this paper
• Significantly Higher Peripheral Insulin-Like Growth Factor-1 Levels in Patients With Major Depressive Disorder or Bipolar Disorder Than in Healthy Controls

  2016cites this paper
• Role of trophic factors GDNF, IGF-1 and VEGF in major depressive disorder: A comprehensive review of human studies.

  2016influential citation
• Biological Rationale for Regular Physical Exercise as an Effective Intervention for the Prevention and Treatment of Depressive Disorders.

  2016cites this paper
• Serum Levels of Insulin-Like Growth Factor-1 and Obsessive-Compulsive Disorder: A Case-Control Study

  2016cites this paper
• Growth factors as clinical biomarkers of prognosis and diagnosis in psychiatric disorders.

  2016cites this paper
• Insulin-Like Growth Factor 1 (IGF-1) in Parkinson's Disease: Potential as Trait-, Progression- and Prediction Marker and Confounding Factors

  2016influential citation
• Plasma insulin-like growth factor I levels are higher in depressive and anxiety disorders, but lower in antidepressant medication users.

  2016cites this paper
• Association of EGF, IGFBP-3 and TP53 Gene Polymorphisms with Major Depressive Disorder in Slovak Population.

  2016cites this paper
• Letter to the Editor

  2015cites this paper
• Summary and General Discussion of the Thesis

  year unknowncites this paper